MedPath

Hybrid: Integrating Virtual Reality, Neurofeedback and Cognitive Behaviour Therapy for Treatment of Hearing Voices in Young People

Not Applicable
Conditions
Early psychosis
Schizophrenia
Mental Health - Schizophrenia
Mental Health - Psychosis and personality disorders
Registration Number
ACTRN12624000357550
Lead Sponsor
Barnaby Nelson
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

1) Aged 15-25 years inclusive.
2) Sufficient fluency in English to engage in psychological therapy with an English-speaking therapist, and to understand the study assessments.
3) Ability to give informed consent and adhere to study procedures. Parental or guardian consent will be obtained for participants aged under 18 years.
4) Psychotic threshold AVH as measured by the Comprehensive Assessment of At Risk Mental States (CAARMS; 5 or 6 on severity and greater than or equal to 4 on frequency for longer than one week; Yung et al., 2005)
5) A current rating of greater than or equal to 3 on the Psychotic Symptom Rating Scales (PSYRATS) hallucinations scale (Drake, Haddock, Tarrier, Bentall, & Lewis, 2007), corresponding to voices occurring at least once/hour. The purpose of this is to ensure that participants with reasonably frequent hallucinations are included in the study, as experience of symptoms during Hybrid sessions will optimise the study’s test of outcomes of interest.

Exclusion Criteria

Exclusion Criteria:
1) Documented history of head injury, seizures, or other significant neurological illness
2) Documented history of intellectual disability
3) Visual impairment precluding ability to view VR scenario

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath